MFA
NVO

Mayflower Financial Advisors’s Novo Nordisk NVO Stock Holding History

Mayflower Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Buy
+5,962
New +$256K 0.02% 390
2026
Q1 		– Sell
-5,601
Closed -$285K – 459
2025
Q4 		$285K Sell
5,601
-1,058
-16% -$54.1K 0.03% 345
2025
Q3 		$369K Sell
6,659
-795
-11% -$46.5K 0.05% 301
2025
Q2 		$514K Buy
7,454
+2,380
+47% +$162K 0.07% 239
2025
Q1 		$352K Sell
5,074
-2,539
-33% -$210K 0.05% 277
2024
Q4 		$655K Buy
7,613
+894
+13% +$96.7K 0.1% 189
2024
Q3 		$800K Buy
6,719
+88
+1% +$11.7K 0.12% 161
2024
Q2 		$946K Buy
6,631
+2,436
+58% +$323K 0.16% 135
2024
Q1 		$539K Buy
4,195
+1,899
+83% +$226K 0.09% 198
2023
Q4 		$238K Buy
2,296
+70
+3% +$6.92K 0.03% 301
2023
Q3 		$202K Buy
+2,226
New +$196K 0.03% 319

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Mayflower Financial Advisors's NVO Position: Q2 2026 in Review

Mayflower Financial Advisors opened a new position in Novo Nordisk (NVO) in Q2 2026: 5,962 shares worth $286K. The stake represents 0.02% of the portfolio and ranks #390 among its holdings. This is a return to the name: Mayflower Financial Advisors previously reported a position in NVO as recently as Q4 2025.

Mayflower Financial Advisors first reported a position in NVO in Q3 2023 and has held it in 11 quarters since. The position peaked at $946K in Q2 2024. 433 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Mayflower Financial Advisors held 5,962 shares of Novo Nordisk worth $286K as of Q2 2026.
  • Novo Nordisk was a new Mayflower Financial Advisors position in Q2 2026.
  • Novo Nordisk made up 0.02% of Mayflower Financial Advisors's portfolio in Q2 2026, its #390 holding.
  • Mayflower Financial Advisors first reported a position in Novo Nordisk in Q3 2023 and has held it in 11 quarters since.
  • Mayflower Financial Advisors's Novo Nordisk position peaked at $946K in Q2 2024.
  • 433 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Mayflower Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.